Dr. Dary Samimi, M.D., F.A.C.O.G.
     Pioneer of Techniques in Nerve Sparing Gynecologic Urogynecologic Surgery

Home

888-4Female.com

Office Goal

This site is devoted to the presentation of techniques in nerve sparing gynecologic surgery pioneered by Dr. Dary Samimi, M.D., F.A.C.O.G. These techniques are done as an outpatient surgical procedure sometimes under local anesthesia. These techniques and the medical device(s) used to assist with the procedure, were created and patented by Dr. Dary Samimi, M.D., F.A.C.O.G., research-Invention, of Fountain Valley, California, USA. [US Patent for the 'Bladder Saver Retropublic Ligature Carrier Device']    ... read more...
Office Location:
P.O. Box 9870
Fountain Valley, Ca. 92728-9870
1-888-4Female
Fax (714) 754-4401

1-888-4Female

EARLY BREAST CANCER DETECTION WHEN MAMMOGRAPHY IS NEGATIVE AND THE LESION NONPALPABLE


Daryoosh Samimi, M.D., F.A.C.O.G.
Researcher - Inventor
Director of US Women Institute
Fountain Valley, California


OBJECTIVE:
To demonstrate that Venus Method can result in detection of early breast cancer. This method of detection of premalignant and malignant breast lesions in patients with negative mammography and nonpalpable tumors results in earlier diagnosis.

METHOD:
VENUS METHOD
We have reviewed all of our gynecological patient's charts from August 1, 1985 to July 31, 2001 (a total of 16 years).
Six thousand four hundred and eighty two (6,482) patients with symptomatic or asymptomatic breast disorders underwent routine Comprehensive Clinical Breast Examination (CBE).
Screening mammography was preformed according to the American Cancer Society (ACS) Guidelines. In this study, patients with breast symptoms, or with asymmetric densities or other suspicious conditions were chosen for the Venus Method. One hundred and thirteen (113) patients were selected for excisional biopsy.

RESULTS:
There were 424 pathological diagnoses in the 113 patients. Final diagnosis of Infiltrating Breast Carcinoma was noted in seventeen cases (of which 9 had undetected by mammography).
Carcinoma insitu of breast was noted in nine cases (of which 6 were undetected by mammography). Atypical hyperplasia was noted in 34 cases (of which 24 were undetected by mammography). One hundred and one surgeries were performed by the author (of 113 surgeries). The Venus Method had a remarkable success rate, with significant reduction in mortality.

CONCLUSION:
This study does not detract from screening mammography, "The Venus Method" is a powerful addition for early detection of breast lesions when mammography is negative and disease is nonpalpable.

1-888-4Female